Christine B. McKinley
Keine laufenden Positionen mehr
Karriereverlauf von Christine B. McKinley
Ehemalige bekannte Positionen von Christine B. McKinley
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Personalreferent | 01.08.1994 | 28.02.2009 |
Nellcor Puritan Bennett, Inc.
 Nellcor Puritan Bennett, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Nellcor Puritan Bennett, Inc. is a company that manufactures and supplies respiratory care products. The company is based in Pleasanton, CA. Nellcor Puritan Bennett was acquired by Mallinckrodt, Inc.(Old) on August 26, 1997 for $1,805.05 million. | Personalreferent | 01.01.1985 | 01.01.1994 |
Ausbildung von Christine B. McKinley
| University of California, Santa Barbara | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Human Resources Officer | 2 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cell Genesys, Inc.
Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
Nellcor Puritan Bennett, Inc.
Nellcor Puritan Bennett, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Nellcor Puritan Bennett, Inc. is a company that manufactures and supplies respiratory care products. The company is based in Pleasanton, CA. Nellcor Puritan Bennett was acquired by Mallinckrodt, Inc.(Old) on August 26, 1997 for $1,805.05 million. | Health Technology |
- Börse
- Insiders
- Christine B. McKinley
- Erfahrung
